AMENDED STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Company

Adaptive Biotechnologies Corp

Filed

May 20, 2025

Period of Report

May 16, 2025

Accession Number

0001062993-25-009904